[The potassium-neutral venodiuretic drug Dehydro sanol tri. Report on the experiences with a new principle for the treatment of leg disorders of venous origin].
D000328:Adult; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006569:Hesperidin / Q000627:therapeutic use*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013831:Thiamine / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use*; D014689:Venous Insufficiency / Q000188:drug therapy*
D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D005419:Flavonoids; D049993:Sodium Chloride Symporter Inhibitors; D006569:Hesperidin; D011188:Potassium; D014223:Triamterene; D013831:Thiamine
Untersuchungen über das kaliumneutrale Venodiuretikum Dehydro sanol tri. Erfahrungsbericht über ein neues Prinzip zur Behandlung venöser Beinleiden